- About Us
- Who we are
- The way we work
- Partners and networks
- Jobs
- Procurement
- Legislation
- REACH
- Understanding REACH
- Substance Identification
- Registration
- Evaluation
- Authorisation
- Restriction
- Candidate List substances in articles
- Communication in the supply chain
- Enforcement
- Legislation
- Animal testing under REACH
- Substitution to safer chemicals
- Screening
- RMOA
- PBT assessment
- Endocrine disruptor assessment
- Cooperation with authorities and stakeholders
- CLP
- BPR
- Understanding BPR
- Upcoming deadlines
- Approval of active substances
- Authorisation of biocidal products
- Technical equivalence
- In situ generated active substances
- Annex I amendment
- Product-types
- Active substances and suppliers
- Treated articles
- BPR Legislation
- Data sharing
- Chemical similarity check service
- Substitution to safer chemicals
- PIC
- CAD/CMD
- WFD
- POPs
- REACH
- Public consultations
- Draft recommendation for inclusion in the Authorisation List and public consultation
- Applications for authorisation consultations
- Consultations on new scientific evidence
- Testing proposals consultation
- Harmonised classification and labelling public consultations
- Submitted restrictions under consideration
- ECHA Executive Director’s requests related to the CLH process
- Current calls for comments and evidence
- Public consultation on potential candidates for substitution
- Public consultation on derogation to the exclusion criteria
- ECHA's Executive Director Requests to the Committees
- Harmonised classification and labelling targeted consultations
- Public consultation on a draft recommendation for amendment of Authorisation List entries
- Public consultations in the authorisation process
- Substances of very high concern identification
- Occupational exposure limits - Call for comments and evidence
- Occupational exposure limits - Previous calls for comments and evidence
- Information on Chemicals
- Registered substances
- Registry of restriction intentions until outcome
- Registry of SVHC intentions until outcome
- Registry of CLH intentions until outcome
- ECHA's current activities on restrictions
- ECHA's completed activities on restriction
- Annex III inventory
- Pre-registered substances
- EC Inventory
- Dossier Evaluation status
- PACT
- Endocrine disruptor assessment list
- PBT assessment list
- Substance evaluation - CoRAP
- RMOA list
- Information on Candidate List substances in articles table
- REACH registration statistics
- C&L Inventory
- Substances restricted under REACH
- Biocidal Active Substances
- Biocidal Products
- List of active substances and suppliers
- Chemicals subject to PIC
- Transitional Measures
- Information from the Existing Substances Regulation (ESR)
- PBT/vPvB assessments under the previous EU chemicals legislation
- Candidate List
- Submitted recommendations
- Adopted opinions and previous consultations on applications for authorisation
- Authorisation List
- Adopted opinions on restriction proposals
- Mapping exercise – Plastic additives initiative
- Occupational exposure limits - Activity list
- List of substances subject to POPs Regulation
- List of substances proposed as POPs
- Addressing substances of concern
- Chemicals in our Life
- Nanomaterials
- Support
- Guidance
- Getting started
- Q&As Support
- Testing methods and alternatives
- Webinars
- Dossier Submission Tools
- Manuals
- REACH-IT
- Registration Process
- PPORD
- Notifying substances in articles
- Submitting downstream user notification of authorised uses
- Submitting a downstream user report for unsupported uses
- Submitting a downstream user report for classification differences
- How to submit and update your C&L notification
- Requesting an alternative chemical name in mixtures
- IUCLID
- CHESAR
- SPC Editor
- R4BP 3
- ePIC
- ECHA Cloud Services
- Validation Assistant
- Interact Portal
- National Helpdesks
- Practical examples of exposure scenarios
- Small and Medium-sized Enterprises (SMEs)
- Registration
- Your registration obligations
- How to characterise and identify your substance
- What you need to submit
- What you need to consider for your business
- Finding your co-registrants
- Working together
- What information you need
- How to avoid unnecessary testing on animals
- Strategy for gathering your data
- Creating your registration dossier
- Submitting your registration dossier
- From submission to decision
- Practical examples – REACH registration
- SME-consultant cooperation
- Changes to joint submissions
- How to get organised for dossier updates
- Practical examples of chemical safety reports
- Substance identification
- Authorisation
- Substances of very high concern identification
- How to apply for authorisation
- Are you affected by authorisation?
- Pre-submission information sessions - terms and conditions of use
- Develop an application strategy
- Submission windows
- Start preparing your application
- Pre-Submission Information Sessions
- Formats for applications for authorisation
- Notify ECHA and request a pre-submission information session
- Previous events on appliction for authorisation
- Finalise your application
- Partners service for applicants
- Submit your application
- Engage during the opinion development
- Ask ECHA about authorisation applications
- Fulfil your obligations
- Evaluating applications
- Information on applying for authorisation by Member States and industry organisations
- Submit a review report if you still need to use the substance
- Restriction
- Submission of CLH dossiers
- Socio-economic analysis in REACH
- QSAR Toolbox
- How to improve your dossier
- Mixture classification
- UK withdrawal from the EU
- Recommendations to registrants
- Contact
- sso
Application and assessment procedure
Companies will apply for inclusion on the list of active substance suppliers through R4BP 3.
This graph shows an overview of the application procedure for inclusion on the list of active substance suppliers.
Steps
The application process has several steps. Each step needs to be completed before the application can move to the next step. It is important that the applicant makes sure that all applicable deadlines are met otherwise the application will be rejected during the course of the process.
ECHA checks that the application and data have been submitted in the correct format and sends the fees invoice through R4BP 3.
The applicant pays the related fees to ECHA within 30 days from the invoice date. The application is inserted in the list of pending Article 95 applications.
ECHA accepts the application and starts the compliance check. Any information gaps or inconsistencies identified in the compliance check are described and compiled in a draft decision. The draft decision is sent to the submitter with a request to respond within a one- month commenting period. This commenting period can be extended by an additional two months upon request.
The applicant submits any comments as well as any additional information within the commenting period.
ECHA will take the final decision on the inclusion of the company in the list of active substance suppliers based on the information available at the end of the commenting period.
Actors
The main actors in the dossier submission process are:
Applicants
Applicants have the responsibility to provide all relevant information related to the active substance suppliers assessment. Applicants are responsible for the quality and format of the data in their applications.
ECHA
ECHA is responsible for checking that the information in the dossiers is in a correct format. ECHA also carries out the assessment of applications and makes sure that the submission process proceeds within the set timelines.
Categories Display
Route: .live2
